2LS Stock Overview
PT Siloam International Hospitals Tbk, together with its subsidiaries, provides healthcare services in Indonesia.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
PT Siloam International Hospitals Tbk Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | Rp0.14 |
| 52 Week High | Rp0.16 |
| 52 Week Low | Rp0.087 |
| Beta | 0.11 |
| 1 Month Change | 8.73% |
| 3 Month Change | 8.73% |
| 1 Year Change | 40.51% |
| 3 Year Change | 139.30% |
| 5 Year Change | 321.54% |
| Change since IPO | 97.12% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2LS | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 2.2% | 2.7% | 0.5% |
| 1Y | 40.5% | -1.8% | 1.3% |
Return vs Industry: 2LS exceeded the German Healthcare industry which returned 0.6% over the past year.
Return vs Market: 2LS exceeded the German Market which returned 2.3% over the past year.
Price Volatility
| 2LS volatility | |
|---|---|
| 2LS Average Weekly Movement | 7.3% |
| Healthcare Industry Average Movement | 6.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 2LS has not had significant price volatility in the past 3 months.
Volatility Over Time: 2LS's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 14,142 | Benny Djie | www.siloamhospitals.com |
PT Siloam International Hospitals Tbk, together with its subsidiaries, provides healthcare services in Indonesia. It also engages in setting up and managing hospitals. The company offers specialist and general medical services, including complex surgical procedures, laboratory services, radiology and imaging services, diagnostic, and emergency services.
PT Siloam International Hospitals Tbk Fundamentals Summary
| 2LS fundamental statistics | |
|---|---|
| Market cap | €1.91b |
| Earnings (TTM) | €69.75m |
| Revenue (TTM) | €644.38m |
27.3x
P/E Ratio3.0x
P/S RatioIs 2LS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2LS income statement (TTM) | |
|---|---|
| Revenue | Rp11.19t |
| Cost of Revenue | Rp6.94t |
| Gross Profit | Rp4.25t |
| Other Expenses | Rp3.04t |
| Earnings | Rp1.21t |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 93.27 |
| Gross Margin | 37.96% |
| Net Profit Margin | 10.82% |
| Debt/Equity Ratio | 5.3% |
How did 2LS perform over the long term?
See historical performance and comparison